Flora Growth Corp. Appoints Harold Wolkin to Board of Directors; Clifford Starke Named Chairman
Flora Growth Corp. (NASDAQ: FLGC) has announced significant changes to its Board of Directors. Harold Wolkin, with over 30 years of finance sector experience, has been appointed as an independent director and will chair the Audit Committee. Wolkin's extensive background includes roles at BMO Capital Markets and Dundee Capital Markets, as well as current board positions at several public companies. Additionally, Clifford Starke, the company's CEO, has been named Chairman of the Board.
Wolkin's appointment is expected to strengthen Flora's financial strategy and governance as it expands globally. His expertise in investment banking and corporate governance, along with his CFA designation and academic background in economics, positions him as a valuable addition to Flora's leadership team.
Flora Growth Corp. (NASDAQ: FLGC) ha annunciato cambiamenti significativi nel suo Consiglio di Amministrazione. Harold Wolkin, con oltre 30 anni di esperienza nel settore finanziario, è stato nominato direttore indipendente e presiederà il Comitato di Revisione. Il vasto background di Wolkin include ruoli presso BMO Capital Markets e Dundee Capital Markets, oltre a posizioni attuali in vari consigli di amministrazione di aziende pubbliche. Inoltre, Clifford Starke, l'amministratore delegato dell'azienda, è stato nominato Presidente del Consiglio.
La nomina di Wolkin si prevede rafforzerà la strategia finanziaria e la governance di Flora mentre si espande a livello globale. La sua esperienza in investment banking e governance aziendale, insieme alla sua designazione CFA e al suo background accademico in economia, lo pongono come un valore aggiunto per il team di leadership di Flora.
Flora Growth Corp. (NASDAQ: FLGC) ha anunciado cambios significativos en su Junta Directiva. Harold Wolkin, con más de 30 años de experiencia en el sector financiero, ha sido nombrado director independiente y presidirá el Comité de Auditoría. La amplia trayectoria de Wolkin incluye roles en BMO Capital Markets y Dundee Capital Markets, así como posiciones actuales en varios consejos de empresas públicas. Además, Clifford Starke, el CEO de la compañía, ha sido nombrado Presidente de la Junta.
Se espera que la designación de Wolkin fortalezca la estrategia financiera y la gobernanza de Flora a medida que se expande globalmente. Su experiencia en banca de inversión y gobernanza corporativa, junto con su designación CFA y su formación académica en economía, lo posicionan como un valioso añadido al equipo de liderazgo de Flora.
플로라 성장 주식회사 (NASDAQ: FLGC)는 이사회에 대한 중요한 변화를 발표했습니다. 해롤드 울킨은 30년 이상의 금융 분야 경력을 가진 독립 이사로 임명되었으며 감사 위원회의 의장을 맡게 됩니다. 울킨의 폭넓은 경력은 BMO 캐피탈 마켓과 던디 캐피탈 마켓에서의 역할, 현재 여러 상장 기업에서의 이사직을 포함합니다. 또한, 클리포드 스타크, 회사의 CEO가 이사회의 의장으로 임명되었습니다.
울킨의 임명이 플로라가 글로벌하게 확장하는 데 있어 재무 전략과 거버넌스를 강화할 것으로 기대됩니다. 투자은행 및 기업 거버넌스 분야의 전문성과 CFA 자격, 경제학에 대한 학문적 배경은 그를 플로라 leadership 팀의 귀중한 추가 인력으로 자리매김하게 합니다.
Flora Growth Corp. (NASDAQ: FLGC) a annoncé des changements significatifs au sein de son conseil d'administration. Harold Wolkin, fort de plus de 30 ans d'expérience dans le secteur financier, a été nommé directeur indépendant et sera président du comité d'audit. Le parcours étendu de Wolkin inclut des rôles chez BMO Capital Markets et Dundee Capital Markets, ainsi que des postes actuels au sein de plusieurs entreprises publiques. De plus, Clifford Starke, le PDG de l'entreprise, a été nommé président du conseil.
La nomination de Wolkin devrait renforcer la stratégie financière et la gouvernance de Flora alors que l'entreprise s'étend à l'échelle mondiale. Son expertise en banque d'investissement et en gouvernance d'entreprise, ainsi que sa désignation CFA et ses antécédents académiques en économie, en font un ajout précieux à l'équipe dirigeante de Flora.
Flora Growth Corp. (NASDAQ: FLGC) hat bedeutende Änderungen in seinem Vorstand bekannt gegeben. Harold Wolkin, der über 30 Jahre Erfahrung im Finanzsektor verfügt, wurde als unabhängiger Direktor ernannt und wird den Prüfungsausschuss leiten. Wolkins umfangreiche Erfahrung umfasst Positionen bei BMO Capital Markets und Dundee Capital Markets sowie aktuelle Vorstandspostitionen in mehreren öffentlichen Unternehmen. Darüber hinaus wurde Clifford Starke, der CEO des Unternehmens, zum Vorsitzenden des Vorstands ernannt.
Die Ernennung von Wolkin wird voraussichtlich die Finanzstrategie und die Governance von Flora stärken, während sich das Unternehmen global ausdehnt. Seine Fachkenntnisse im Investment Banking und in der Unternehmensführung sowie seine CFA-Bezeichnung und akademische Ausbildung in Volkswirtschaftslehre machen ihn zu einem wertvollen Mitglied des Führungsteams von Flora.
- Appointment of Harold Wolkin, an experienced finance professional, as independent director and Audit Committee Chair
- Wolkin's extensive background in investment banking and corporate governance could enhance Flora's financial strategy
- Clifford Starke's appointment as Chairman of the Board, consolidating leadership
- None.
Fort Lauderdale, Florida--(Newsfile Corp. - September 12, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") is pleased to announce the appointment of Harold Wolkin as an independent director on its Board of Directors. In this role, Mr. Wolkin will also serve as a member of each of the Company's committees, including as Chair of the Audit Committee.
Mr. Wolkin brings over 30 years of progressive experience in the finance sector, having held significant roles in investment banking, including positions at BMO Capital Markets and Dundee Capital Markets. His extensive background and expertise will be instrumental in guiding Flora's financial strategy and governance as the Company continues to expand its global operations.
In addition to his new role at Flora, Mr. Wolkin currently serves on the boards of several publicly listed companies. He is the Audit Committee Chair at Baylin Technologies Inc. (TSX: BYL), the Lead Independent Director and Audit Committee Chair at Cipher Pharmaceuticals (TSX: CPH), Chairman of Femto Technologies Inc. (NASDAQ: BCAN). Mr. Wolkin has also made notable contributions to the financial community as a past President of the CFA Society Toronto, and he has been a member of the Chartered Financial Institute since 1980, holding the Chartered Financial Analyst (CFA) designation.
Mr. Wolkin holds a Bachelor of Arts in Economics from York University and a Master of Arts in Economics and Finance from the University of Toronto. He is also a graduate and member of the Institute of Corporate Directors, further underscoring his commitment to excellence in corporate governance.
Concurrently with Mr. Wolkin's appointment, Flora is pleased to announce the appointment of Mr. Clifford Starke as Chairman of the Board of Directors. Mr. Starke is currently the Chief Executive Officer of the Company.
"I would like to welcome Harold Wolkin to the Board of Directors," said Clifford Starke, Chairman and Chief Executive Officer. "His deep understanding of financial markets and strategic insights will be invaluable as we continue to scale our business globally. Harold's experience will not only strengthen our governance but will also help us to explore new opportunities and navigate the complexities of the international cannabis market. I look forward to the fresh perspectives and leadership he will bring to our team."
"I am honored to join Flora as such an important time in the Company's development," said Harold Wolkin. "I am excited to work alongside such a dynamic leadership team and to contribute to Flora's continued success. Together, we will focus on enhancing shareholder value, exploring strategic growth avenues, and ensuring the highest standards of corporate governance."
About Flora Growth Corp.
Flora Growth Corp. is a consumer-packaged goods leader and pharmaceutical distributor serving all 50 states and 28 countries with 20,000+ points of distribution around the world. For more information on Flora, visit www.floragrowth.com.
https://www.phatebo.de/home-en
https://www.australianvaporizers.com.au/
Investor Relations:
Investor Relations ir@floragrowth.com
Clifford Starke Clifford.Starke@floragrowth.com
Media:
Cautionary Statement Concerning Forward-Looking Statements
This press release contains "forward-looking statements," as defined by U.S. federal securities laws. Forward-Looking statements reflect Flora's current expectations and projections about future events at the time, and thus involve uncertainty and risk. The words "believe," "expect," "anticipate," "will," "could," "would," "should," "may," "plan," "estimate," "intend," "predict," "potential," "continue," and the negatives of these words and other similar expressions generally identify forward-looking statements. These forward-looking statements include, but are not limited to, statements about: Harold Wolkin being instrumental in guiding Flora's financial strategy and governance, Flora's continued ability to expand its global operations as well as Harold Wolkin's contribution to such expansions, and Flora scaling its business globally. Such forward-looking statements are subject to various and risks and uncertainties, including those described under section entitled "Risk Factors" in Flora's Annual Report on Form 10-K filed with the United States Securities and Exchange Commission (the "SEC") on March 28, 2024, as such factors may be updated from time to time in Flora's periodic filings with the SEC, which are accessible on the SEC's website at www.sec.gov/edgar. Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this release and in Flora's filings with the SEC. While forward-looking statements reflect Flora's good faith beliefs, they are not guarantees of future performance. Flora disclaims any obligation to publicly update or revise any forward-looking statement to reflect changes in underlying assumptions or factors, new information, data or methods, future events or other changes after the date of this press release, except as required by applicable law. You should not place undue reliance on any forward-looking statements, which are based on information currently available to Flora (or to third parties making the forward-looking statements).
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/223077
FAQ
Who is the new independent director appointed to Flora Growth Corp's (FLGC) Board?
What experience does Harold Wolkin bring to Flora Growth Corp (FLGC)?
Who has been appointed as the new Chairman of Flora Growth Corp's (FLGC) Board?
How might Harold Wolkin's appointment impact Flora Growth Corp (FLGC)?
